SARS‐CoV‐2 and the hidden carriers: Sewage, feline, and blood transfusion

Ali, Muhammad; Zaid, Muhammad; Saqib, Muhammad Arif Nadeem; Ahmed, Haroon; Afzal, Muhammad Sohail

doi:10.1002/jmv.25956

Cited by 12 publications

(11 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The calculated viral RNA copy numbers determine the number of infected individuals. The increasing reports of virus shedding via the fecal route warrants the introduction of negative fecal viral nucleic acid test results as one of the additional discharge criteria in laboratory-confirmed cases of COVID-19 ( 326 ).…”

Section: Current Worldwide Scenario Of Sars-cov-2mentioning

confidence: 99%

“…The similarity observed in the gene sequence of SARS-CoV-2 from an infected pet owner and his dog further confirms the occurrence of human-to-animal transmission ( 333 ). Even though asymptomatic, feline species should be considered a potential transmission route from animals to humans ( 326 ). However, currently, there are no reports of SARS-CoV-2 transmission from felines to human beings.…”

Section: Coronaviruses In Animals and Zoonotic Links—a Brief Viewpoinmentioning

confidence: 99%

See 1 more Smart Citation

Coronavirus Disease 2019–COVID-19

et al. 2020

View full text Add to dashboard Cite

SUMMARY In recent decades, several new diseases have emerged in different geographical areas, with pathogens including Ebola virus, Zika virus, Nipah virus, and coronaviruses (CoVs). Recently, a new type of viral infection emerged in Wuhan City, China, and initial genomic sequencing data of this virus do not match with previously sequenced CoVs, suggesting a novel CoV strain (2019-nCoV), which has now been termed severe acute respiratory syndrome CoV-2 (SARS-CoV-2). Although coronavirus disease 2019 (COVID-19) is suspected to originate from an animal host (zoonotic origin) followed by human-to-human transmission, the possibility of other routes should not be ruled out. Compared to diseases caused by previously known human CoVs, COVID-19 shows less severe pathogenesis but higher transmission competence, as is evident from the continuously increasing number of confirmed cases globally. Compared to other emerging viruses, such as Ebola virus, avian H7N9, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 has shown relatively low pathogenicity and moderate transmissibility. Codon usage studies suggest that this novel virus has been transferred from an animal source, such as bats. Early diagnosis by real-time PCR and next-generation sequencing has facilitated the identification of the pathogen at an early stage. Since no antiviral drug or vaccine exists to treat or prevent SARS-CoV-2, potential therapeutic strategies that are currently being evaluated predominantly stem from previous experience with treating SARS-CoV, MERS-CoV, and other emerging viral diseases. In this review, we address epidemiological, diagnostic, clinical, and therapeutic aspects, including perspectives of vaccines and preventive measures that have already been globally recommended to counter this pandemic virus.

show abstract

Section: Current Worldwide Scenario Of Sars-cov-2mentioning

confidence: 99%

Section: Coronaviruses In Animals and Zoonotic Links—a Brief Viewpoinmentioning

confidence: 99%

Coronavirus Disease 2019–COVID-19

et al. 2020

View full text Add to dashboard Cite

show abstract

“…CoV-2 has a severe impact on world economy 11 and due to several potential unnoticed transmission routes, it will test the health care system for a longer time. 12…”

Section: Sars-mentioning

confidence: 99%

COVID‐19 and dengue virus coepidemics in Pakistan: A dangerous combination for an overburdened healthcare system

Haqqi

Awan

Ali

et al. 2020

Journal of Medical Virology

Self Cite

View full text Add to dashboard Cite

“…The risk for SARS-CoV-2 transmission through blood components in asymptomatic SARS-CoV-2 infected individuals is yet to be established. This problem could be overcome through improving blood biosafety protection, following standard measures for the virus inactivation in blood products, and questioning the health condition of blood donors and their relatives for a period after donation (63,64). In addition, we observed that, during COVID-19 the blood donor pool and blood supplies reduced due to the hesitation of donors.…”

Section: Blood Productsmentioning

confidence: 95%

Lösemili Çocuklarda SARS COV-2 Enfeksiyonu

Erdem¹,

Özbek²

2020

Turkish Journal of Pediatric Disease

View full text Add to dashboard Cite

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directed great attention and anxiety all over the world. Epidemiologic models predict that the current COVID-19 pandemic will last several months or even several years, until the development of a vaccine and/or herd immunity. Although the course of the infection is often not severe in children, it can be life threatening especially in immunocompromised children with leukemia. Hematopoietic and lymphoid cancers are accounting for approximately 40% of all childhood cancers. The five-year survival rate for childhood cancer has approached to 70% and more than 80% for leukemia in our country. During COVID pandemic, children with leukemia may also have COVID-19 infection, especially when their bone marrow is depressed due to chemotherapy. It is observed that factors such as the underlying type of cancer, status of remission, or having stem cell transplantation may affect the prognosis. As well as standard and proven treatments for febrile neutropenia, all tests and treatments should be applied very quickly and properly for COVID 19 as is all suspected patients. These efforts may contribute to increase the survival of our children with cancer. Given the absence of data to address concerns related to SARS-CoV-2 infection while on chemotherapy, questions are increasing about the approach for management of systemic immunosuppressive therapies, i.e. ceasing or reducing the immunosuppressive medications in children with leukemia.The current rapid worldwide spread of COVID-19 necessitates identifying optimal preventive strategies and effective medical management. In this report, we tried to review appropriate literature-based approaches for prevention, diagnosis and management of treatment protocols for children with cancer during the pandemic period.

show abstract

SARS‐CoV‐2 and the hidden carriers: Sewage, feline, and blood transfusion

Cited by 12 publications

References 10 publications

Coronavirus Disease 2019–COVID-19

Coronavirus Disease 2019–COVID-19

COVID‐19 and dengue virus coepidemics in Pakistan: A dangerous combination for an overburdened healthcare system

Lösemili Çocuklarda SARS COV-2 Enfeksiyonu

Contact Info

Product

Resources

About